+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Non-iodinated X-ray Contrast Agents Market - Global Forecast 2026-2032- Product Image
Non-iodinated X-ray Contrast Agents Market - Global Forecast 2026-2032- Product Image
Sale

Non-iodinated X-ray Contrast Agents Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6145663
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Non-iodinated X-ray Contrast Agents Market is projected to reach USD 2.87 Billion in 2026. It is expected to continue growing at a CAGR of 9.64%, reaching USD 5.08 Billion by 2032.

Non-Iodinated X-Ray Contrast Agents: Executive Overview

Non-iodinated X-ray contrast agents support diagnostic imaging applications where clinicians seek alternatives to conventional iodinated media or require specialized contrast behavior. Their relevance is shaped by patient-specific safety considerations, imaging performance, regulatory requirements, procedure volumes, and the availability of complementary modalities. Adoption decisions typically depend on clinical evidence, workflow compatibility, supply reliability, and total treatment economics rather than on a single technical attribute.

Clinical Personalization and Imaging Workflow Are Reshaping Adoption

The landscape is being transformed by greater attention to individualized imaging protocols, renal and hypersensitivity risk assessment, radiation-conscious care, and demand for more efficient diagnostic pathways. Hospitals and imaging providers are also emphasizing interoperability with modern scanners, standardized administration procedures, staff training, and quality assurance. These shifts favor products supported by robust clinical documentation, clear labeling, dependable logistics, and evidence that they can integrate into routine workflows without adding avoidable complexity.

Artificial Intelligence Elevates Selection, Protocol Design, and Quality Control

Artificial intelligence is influencing this field primarily through image reconstruction, protocol optimization, automated triage, and decision support. AI-enabled systems can help clinicians tailor examination parameters, identify technically inadequate studies, and prioritize follow-up, while machine-learning tools may support consistency across operators and sites. However, AI does not remove the need for validated contrast-agent performance, clinical oversight, transparent data governance, cybersecurity controls, and prospective assessment of bias and diagnostic reliability.

Regional Insights: Regulation, Infrastructure, and Access Shape Market Conditions

North America combines advanced imaging infrastructure with stringent regulatory and health-system requirements, encouraging evidence-led adoption and workflow integration. Europe places strong emphasis on harmonized safety standards, procurement discipline, and cross-border regulatory alignment. Asia-Pacific presents varied conditions, ranging from highly developed imaging systems to rapidly expanding access and uneven specialist capacity. Latin America is influenced by import dependence, reimbursement diversity, and concentration of advanced services in major urban centers. The Middle East is investing in specialized healthcare infrastructure while prioritizing workforce development and supply resilience. Africa remains highly heterogeneous, with access shaped by equipment availability, financing, maintenance capability, and diagnostic workforce constraints.

Group Insights: Economic Blocs and Alliances Create Distinct Operating Priorities

ASEAN markets reflect varied regulatory maturity, healthcare financing, and dependence on imported imaging supplies, making regional registration and distributor capability important. BRICS economies combine large and diverse healthcare systems with growing interest in domestic capacity, affordability, and technology access. The European Union emphasizes coordinated regulation, patient safety, procurement transparency, and cross-border standards. G7 systems generally prioritize advanced clinical evidence, quality management, and integration into sophisticated care pathways. GCC countries are strengthening tertiary and diagnostic infrastructure while seeking reliable supply and specialized expertise. NATO members span different health systems but share interest in resilience, continuity of medical supply, and secure digital infrastructure.

Country Insights: National Health-System Conditions Influence Use Cases

Australia and Canada emphasize centralized or regionally coordinated procurement, clinical governance, and access across geographically dispersed populations. The United States is shaped by complex reimbursement, hospital purchasing, regulatory scrutiny, and advanced imaging utilization. Brazil and Mexico face regional disparities, import and distribution considerations, and uneven access between private and public providers. China and India combine large patient populations with differing levels of hospital capability, domestic manufacturing development, and urban-rural access. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have mature imaging ecosystems, but adoption is differentiated by reimbursement rules, procurement structures, clinical guidelines, and national approaches to health technology assessment. Russia’s environment is influenced by healthcare modernization needs, supply-chain resilience, and regulatory and access conditions.

Priorities for Leaders: Build Evidence, Resilience, and Workflow Value

Industry leaders should prioritize clinically credible evidence for relevant patient groups and examination types, while maintaining clear safety communication and disciplined post-market monitoring. Product development should focus on compatibility with contemporary imaging workflows, practical administration, storage, and training requirements. Organizations should diversify critical inputs, qualify alternative logistics routes, and strengthen quality systems to reduce disruption risk. Responsible AI deployment requires validated performance, human review, cybersecurity, and transparent governance. Regional strategies should be adapted to reimbursement, regulatory, infrastructure, and workforce realities rather than copied across geographies.

Research Methodology: Structured Synthesis of Verified Market Evidence

This executive summary uses the defined market scope of non-iodinated X-ray contrast agents and organizes findings across technology, clinical workflow, regulation, infrastructure, geography, and healthcare-system characteristics. The analysis distinguishes documented industry conditions from interpretation, excludes unsupported numerical claims, and avoids estimates, forecasts, market shares, and company-specific positioning. Regional, group, and country observations are presented as contextual insights requiring validation against current regulatory publications, clinical guidance, procurement records, peer-reviewed evidence, and health-system data before strategic decisions are made.

Conclusion: Evidence-Led Integration Will Define Sustainable Progress

The trajectory of non-iodinated X-ray contrast agents will depend on their ability to deliver clinically meaningful value within increasingly personalized, digitally enabled, and resource-conscious imaging systems. Strong safety evidence, dependable supply, regulatory alignment, and seamless workflow integration are central to adoption. Leaders that combine disciplined evidence generation with region-specific implementation, responsible AI practices, and resilient operating models will be better positioned to address evolving diagnostic needs without compromising patient protection or care quality.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Non-iodinated X-ray Contrast Agents Market, by Product Type
7.1. Introduction
7.2. Barium Contrast Media
7.2.1. Standard-density Barium Suspensions
7.2.2. High-density Barium Suspensions
7.2.3. Barium Enema Formulations
7.3. Gadolinium Contrast Media For X-ray
7.3.1. Intravascular Gadolinium Agents
7.3.2. Intra-articular Gadolinium Agents
7.4. Gas Contrast Media
7.4.1. Carbon Dioxide Contrast Media
7.4.2. Room Air Contrast Media
7.5. Non-iodinated Nanoparticle Contrast Media
7.5.1. Metal-based Nanoparticle Agents
7.5.2. Polymer-based Nanoparticle Agents
8. Non-iodinated X-ray Contrast Agents Market, by Route Of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.4. Rectal
9. Non-iodinated X-ray Contrast Agents Market, by Formulation
9.1. Introduction
9.2. Powder
9.3. Suspension
10. Non-iodinated X-ray Contrast Agents Market, by Application
10.1. Introduction
10.2. Angiography
10.2.1. Cerebral Artery
10.2.2. Coronary Artery
10.2.3. Peripheral Artery
10.3. Gastrointestinal Imaging
10.3.1. Lower Gastrointestinal
10.3.2. Upper Gastrointestinal
11. Non-iodinated X-ray Contrast Agents Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.2.1. Imaging Centers
11.2.2. Outpatient Clinics
11.3. Diagnostic Centers
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Non-iodinated X-ray Contrast Agents Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Non-iodinated X-ray Contrast Agents Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Non-iodinated X-ray Contrast Agents Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Bayer AG
16.2. Beijing Beilu Pharmaceutical Co., Ltd.
16.3. Bracco Imaging S.p.A.
16.4. CMC Contrast AB
16.5. Fresenius Kabi AG
16.6. FUJIFILM Corporation
16.7. GE HealthCare Technologies Inc.
16.8. Guerbet
16.9. IMAX Diagnostic Imaging Limited
16.10. J.B. Chemicals & Pharmaceuticals Ltd.
16.11. Jiangsu Hengrui Medicine Co., Ltd.
16.12. Lantheus Holdings, Inc.
16.13. Merck KGaA
16.14. Nano Therapeutics Pvt. Ltd.
16.15. Spago Nanomedical AB
16.16. Taejoon Pharm Co., Ltd.
16.17. Trivitron Healthcare Pvt. Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Non-iodinated X-ray Contrast Agents Market, Years Considered for the Study
FIGURE 2. Global Non-iodinated X-ray Contrast Agents Market, Research Design
FIGURE 3. Global Non-iodinated X-ray Contrast Agents Market, Research Framework
FIGURE 4. Global Non-iodinated X-ray Contrast Agents Market, Data Triangulation
FIGURE 5. Global Non-iodinated X-ray Contrast Agents Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 11. Global Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Non-iodinated X-ray Contrast Agents Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Non-iodinated X-ray Contrast Agents Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Non-iodinated X-ray Contrast Agents Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Non-iodinated X-ray Contrast Agents Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Non-iodinated X-ray Contrast Agents Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Non-iodinated X-ray Contrast Agents Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Non-iodinated X-ray Contrast Agents Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Non-iodinated X-ray Contrast Agents Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Non-iodinated X-ray Contrast Agents Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Non-iodinated X-ray Contrast Agents Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Non-iodinated X-ray Contrast Agents Market Segmentation & Coverage
TABLE 2. Global Non-iodinated X-ray Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 3. Global Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Barium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Barium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Barium Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Standard-density Barium Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Standard-density Barium Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Standard-density Barium Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global High-density Barium Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global High-density Barium Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global High-density Barium Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Barium Enema Formulations Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Barium Enema Formulations Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Barium Enema Formulations Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Gadolinium Contrast Media For X-ray Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Gadolinium Contrast Media For X-ray Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Gadolinium Contrast Media For X-ray Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Intravascular Gadolinium Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Intravascular Gadolinium Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Intravascular Gadolinium Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Intra-articular Gadolinium Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Intra-articular Gadolinium Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Intra-articular Gadolinium Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Gas Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Gas Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Gas Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Carbon Dioxide Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Carbon Dioxide Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Carbon Dioxide Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Room Air Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Room Air Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Room Air Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Non-iodinated Nanoparticle Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Non-iodinated Nanoparticle Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Non-iodinated Nanoparticle Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Metal-based Nanoparticle Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Metal-based Nanoparticle Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Metal-based Nanoparticle Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Polymer-based Nanoparticle Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Polymer-based Nanoparticle Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Polymer-based Nanoparticle Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 44. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Rectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Rectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Rectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 54. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 61. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Cerebral Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Cerebral Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Cerebral Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Coronary Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Coronary Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Coronary Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Peripheral Artery Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Peripheral Artery Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Peripheral Artery Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Gastrointestinal Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Gastrointestinal Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Gastrointestinal Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Lower Gastrointestinal Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Lower Gastrointestinal Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Lower Gastrointestinal Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Upper Gastrointestinal Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Upper Gastrointestinal Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Upper Gastrointestinal Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Outpatient Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Outpatient Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Outpatient Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 119. North America Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. North America Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. North America Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 122. North America Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 123. North America Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 124. North America Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 125. North America Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 126. North America Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 127. North America Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. North America Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 129. North America Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 130. North America Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. North America Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 132. North America Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 133. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 136. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 137. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 138. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 139. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 140. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 141. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 143. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 144. Latin America Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 146. Latin America Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 147. Europe Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Europe Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Europe Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 150. Europe Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 151. Europe Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 152. Europe Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 153. Europe Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 154. Europe Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 155. Europe Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Europe Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 157. Europe Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 158. Europe Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Europe Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 160. Europe Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 164. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 165. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 166. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 167. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 168. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 169. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 171. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 172. Middle East Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 174. Middle East Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 175. Africa Non-iodinated X-ray Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Africa Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Africa Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 178. Africa Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 179. Africa Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 180. Africa Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 181. Africa Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 182. Africa Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 183. Africa Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Africa Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 185. Africa Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 186. Africa Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Africa Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 188. Africa Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 189. Global Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 192. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 193. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 194. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 195. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 196. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 197. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 198. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 200. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 201. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 203. ASEAN Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 204. GCC Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. GCC Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. GCC Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 207. GCC Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 208. GCC Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 209. GCC Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 210. GCC Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 211. GCC Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 212. GCC Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. GCC Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 214. GCC Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 215. GCC Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. GCC Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 217. GCC Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 218. European Union Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. European Union Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. European Union Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 221. European Union Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 222. European Union Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 223. European Union Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 224. European Union Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 225. European Union Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 226. European Union Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. European Union Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 228. European Union Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 229. European Union Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. European Union Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 231. European Union Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 232. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 235. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 236. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 237. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 238. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 239. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 240. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 242. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 243. BRICS Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 245. BRICS Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 246. G7 Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. G7 Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. G7 Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 249. G7 Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 250. G7 Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 251. G7 Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 252. G7 Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 253. G7 Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 254. G7 Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. G7 Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 256. G7 Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 257. G7 Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. G7 Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 259. G7 Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 260. NATO Non-iodinated X-ray Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. NATO Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. NATO Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 263. NATO Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 264. NATO Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 265. NATO Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 266. NATO Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 267. NATO Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 268. NATO Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 269. NATO Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 270. NATO Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 271. NATO Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. NATO Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 273. NATO Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 274. Global Non-iodinated X-ray Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 275. United States Non-iodinated X-ray Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 276. United States Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 277. United States Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 278. United States Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 279. United States Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 280. United States Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 281. United States Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 282. United States Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 283. United States Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. United States Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 285. United States Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 286. United States Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. United States Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 288. United States Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 289. Canada Non-iodinated X-ray Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 290. Canada Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. Canada Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 292. Canada Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 293. Canada Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 294. Canada Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 295. Canada Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 296. Canada Non-iodinated X-ray Contrast Agents Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 297. Canada Non-iodinated X-ray Contrast Agents Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. Canada Non-iodinated X-ray Contrast Agents Market Size, by Angiography, 2017-2032 (USD Million)
TABLE 299. Canada Non-iodinated X-ray Contrast Agents Market Size, by Gastrointestinal Imaging, 2017-2032 (USD Million)
TABLE 300. Canada Non-iodinated X-ray Contrast Agents Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. Canada Non-iodinated X-ray Contrast Agents Market Size, by Ambulatory Care, 2017-2032 (USD Million)
TABLE 302. Canada Non-iodinated X-ray Contrast Agents Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 303. Mexico Non-iodinated X-ray Contrast Agents Market Size, 2017-2032 (USD Million)
TABLE 304. Mexico Non-iodinated X-ray Contrast Agents Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. Mexico Non-iodinated X-ray Contrast Agents Market Size, by Barium Contrast Media, 2017-2032 (USD Million)
TABLE 306. Mexico Non-iodinated X-ray Contrast Agents Market Size, by Gadolinium Contrast Media For X-ray, 2017-2032 (USD Million)
TABLE 307. Mexico Non-iodinated X-ray Contrast Agents Market Size, by Gas Contrast Media, 2017-2032 (USD Million)
TABLE 308. Mexico Non-iodinated X-ray Contrast Agents Market Size, by Non-iodinated Nanoparticle Contrast Media, 2017-2032 (USD Million)
TABLE 309. Mexico Non-iodinated X-ray Contrast Agents Market Size, by Route Of Administration, 2017-2032 (USD Million)
TA

Companies Mentioned

  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Imaging S.p.A.
  • CMC Contrast AB
  • Fresenius Kabi AG
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Guerbet
  • IMAX Diagnostic Imaging Limited
  • J.B. Chemicals & Pharmaceuticals Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Lantheus Holdings, Inc.
  • Merck KGaA
  • Nano Therapeutics Pvt. Ltd.
  • Spago Nanomedical AB
  • Taejoon Pharm Co., Ltd.
  • Trivitron Healthcare Pvt. Ltd.

Related Topics

Related Reports

X-Ray Contrast Media Market - Global Forecast 2026-2032 - Product Image

X-Ray Contrast Media Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Iodinated X-Ray Contrast Media Market - Global Forecast 2026-2032 - Product Image

Iodinated X-Ray Contrast Media Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
X-ray Angiography System Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

X-ray Angiography System Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 79 Pages
  • Global
From
X-ray Films - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

X-ray Films - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 167 Pages
  • Global
From
Medical X-ray Image Processors - Global Strategic Business Report - Product Image

Medical X-ray Image Processors - Global Strategic Business Report

  • Report
  • 374 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.